
Nathaniel Herzfeld
Examiner (ID: 2727, Phone: (571)272-5899 , Office: P/3749 )
| Most Active Art Unit | 3762 |
| Art Unit(s) | 3743, 3749, 3762 |
| Total Applications | 626 |
| Issued Applications | 427 |
| Pending Applications | 1 |
| Abandoned Applications | 203 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18301108
[patent_doc_number] => 11622994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Therapy for vitiligo
[patent_app_type] => utility
[patent_app_number] => 15/714627
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8660
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/714627 | Therapy for vitiligo | Sep 24, 2017 | Issued |
Array
(
[id] => 16954918
[patent_doc_number] => 11058746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Use of immunomodulatory protein from
[patent_app_type] => utility
[patent_app_number] => 15/714218
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 5
[patent_no_of_words] => 3192
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/714218 | Use of immunomodulatory protein from | Sep 24, 2017 | Issued |
Array
(
[id] => 15360943
[patent_doc_number] => 20200016236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => TREATMENT OF AGE-RELATED MACULAR DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/335441
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335441
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335441 | Treatment of age-related macular degeneration | Sep 21, 2017 | Issued |
Array
(
[id] => 12641238
[patent_doc_number] => 20180105577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => ALBUMIN VARIANTS
[patent_app_type] => utility
[patent_app_number] => 15/709261
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709261
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709261 | ALBUMIN VARIANTS | Sep 18, 2017 | Abandoned |
Array
(
[id] => 12239929
[patent_doc_number] => 20180072792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'ALBUMIN VARIANTS'
[patent_app_type] => utility
[patent_app_number] => 15/709227
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 28785
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709227 | ALBUMIN VARIANTS | Sep 18, 2017 | Abandoned |
Array
(
[id] => 12641241
[patent_doc_number] => 20180105578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => ALBUMIN VARIANTS
[patent_app_type] => utility
[patent_app_number] => 15/709263
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709263
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709263 | ALBUMIN VARIANTS | Sep 18, 2017 | Abandoned |
Array
(
[id] => 12641235
[patent_doc_number] => 20180105576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => ALBUMIN VARIANTS
[patent_app_type] => utility
[patent_app_number] => 15/709169
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709169
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709169 | ALBUMIN VARIANTS | Sep 18, 2017 | Abandoned |
Array
(
[id] => 12233168
[patent_doc_number] => 20180066031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'ENZYMATICALLY-CLEAVABLE PEPTIDE AMPHIPHILES'
[patent_app_type] => utility
[patent_app_number] => 15/693739
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15952
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/693739 | ENZYMATICALLY-CLEAVABLE PEPTIDE AMPHIPHILES | Aug 31, 2017 | Abandoned |
Array
(
[id] => 14621813
[patent_doc_number] => 20190224274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => MIF INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/330061
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330061 | MIF INHIBITORS AND METHODS OF USE THEREOF | Aug 30, 2017 | Abandoned |
Array
(
[id] => 14896955
[patent_doc_number] => 20190292243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => PEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/326154
[patent_app_country] => US
[patent_app_date] => 2017-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326154
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326154 | PEPTIDES AND METHODS OF USE THEREOF | Aug 21, 2017 | Abandoned |
Array
(
[id] => 13702645
[patent_doc_number] => 20170362277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/676851
[patent_app_country] => US
[patent_app_date] => 2017-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15676851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/676851 | Cyclosporine analogue mixtures and their use as immunomodulating agents | Aug 13, 2017 | Issued |
Array
(
[id] => 17179376
[patent_doc_number] => 11156614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen
[patent_app_type] => utility
[patent_app_number] => 15/668101
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7378
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15668101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/668101 | Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen | Aug 2, 2017 | Issued |
Array
(
[id] => 12051456
[patent_doc_number] => 20170327800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS'
[patent_app_type] => utility
[patent_app_number] => 15/663361
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 36952
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15663361
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/663361 | METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS | Jul 27, 2017 | Abandoned |
Array
(
[id] => 12030829
[patent_doc_number] => 20170320928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'ALPHA/BETA-POLYPEPTIDE ANALOGS OF GLUCAGON-LIKE PEPTIDE 1'
[patent_app_type] => utility
[patent_app_number] => 15/648937
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11719
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648937
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648937 | Alpha/beta-polypeptide analogs of glucagon-like peptide 1 | Jul 12, 2017 | Issued |
Array
(
[id] => 18153171
[patent_doc_number] => 11566133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Gelatin polymer derived from natural sources of cold-adapted marine species and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/310780
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 52
[patent_no_of_words] => 20174
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310780 | Gelatin polymer derived from natural sources of cold-adapted marine species and uses thereof | Jun 18, 2017 | Issued |
Array
(
[id] => 11942088
[patent_doc_number] => 20170246240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'Antibacterial Peptide and Method of Treatment Using the Antibacterial Peptide'
[patent_app_type] => utility
[patent_app_number] => 15/595313
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9425
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15595313
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/595313 | Antibacterial peptide and method of treatment using the antibacterial peptide | May 14, 2017 | Issued |
Array
(
[id] => 15296049
[patent_doc_number] => 20190391160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => METHODS AND COMPOSITIONS FOR MODIFYING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/097293
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097293
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097293 | METHODS AND COMPOSITIONS FOR MODIFYING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR ACTIVITY | Apr 27, 2017 | Abandoned |
Array
(
[id] => 12023640
[patent_doc_number] => 20170313740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'METHODS OF PREPARING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/499793
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21350
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/499793 | METHODS OF PREPARING PEPTIDES | Apr 26, 2017 | Abandoned |
Array
(
[id] => 16353107
[patent_doc_number] => 10793608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Hypersensitive response elicitor-derived peptides and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/476082
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22775
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476082
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476082 | Hypersensitive response elicitor-derived peptides and use thereof | Mar 30, 2017 | Issued |
Array
(
[id] => 14230513
[patent_doc_number] => 20190127429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => CONJUGATES OF ISLET NEOGENESIS PEPTIDES AND ANALOGS, AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/074073
[patent_app_country] => US
[patent_app_date] => 2017-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074073 | Conjugates of islet neogenesis peptides and analogs, and methods thereof | Mar 8, 2017 | Issued |